阿库提斯生物制药 ARQT
$25.55 −$1.45 (-5.37%)
休市 · Nov 8, 5:10 am ET · 最新盘后价 $25.55 0.00%
开盘$26.70
昨收$27.00
当日区间$25.29 – $27.09
成交量3.26M
市值$3.23B
市盈率（TTM）116.1
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$129.86M+59.3% YoY
营业利润$16.43M+212.4% YoY
净利润$15.01M+194.5% YoY
摊薄每股收益$0.11+184.6% YoY
自由现金流$12.48M+228.0% YoY
经营现金流$12.64M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率91.1%
营业利润率7.4%
净利率6.1%
净资产收益率15.9%
资产收益率6.8%
投入资本回报率11.4%
流动比率2.92
负债/资产比率54.8%
现金及投资$238.55M
总负债$114.14M
净现金（净负债）$124.42M
自由现金流/营收8.4%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $129.86M | $105.40M | $376.07M | $129.50M | $99.22M |
| 营业总收入 | $129.86M | $105.40M | $376.07M | $129.50M | $99.22M |
| 营业成本 | $10.94M | $9.78M | $36.70M | $11.69M | $8.69M |
| 毛利润 | $118.92M | $95.61M | $339.38M | $117.82M | $90.53M |
| 营业费用 | $102.49M | $104.70M | $351.60M | $99.43M | $82.01M |
| 销售及管理费用 | $82.14M | $74.08M | $274.55M | $78.98M | $62.40M |
| 研发费用 | $20.36M | $30.63M | $77.05M | $20.45M | $19.60M |
| 营业利润 | $16.43M | -$9.09M | -$12.23M | $18.39M | $8.53M |
| 非经营性利息净收入（支出） | -$1.13M | -$2.09M | -$3.19M | $5.90M | -$3.07M |
| 非经营性利息收入 | $2.28M | $2.28M | $8.90M | – | – |
| 非经营性利息支出 | $3.41M | $4.37M | $12.08M | $3.00M | $3.07M |
| 其他收入（支出） | -$157,000.00 | -$20,000.00 | $443,000.00 | -$6.42M | $2.04M |
| 其他非经营性收入（支出） | -$157,000.00 | -$20,000.00 | $443,000.00 | -$6.42M | $2.04M |
| 税前利润 | $15.15M | -$11.20M | -$14.97M | $17.87M | $7.49M |
| 税费 | $136,000.00 | $93,000.00 | $1.17M | $470,000.00 | $80,000.00 |
| 净利润 | $15.01M | -$11.30M | -$16.14M | $17.40M | $7.41M |
| 持续经营利润 | $15.01M | -$11.30M | -$16.14M | $17.40M | $7.41M |
| 归属母公司净利润 | $15.01M | -$11.30M | -$16.14M | $17.40M | $7.41M |
| 归属普通股股东净利润 | $15.01M | -$11.30M | -$16.14M | $17.40M | $7.41M |
| 基本每股收益 | $0.11 | -$0.09 | -$0.13 | $0.14 | $0.06 |
| 摊薄每股收益 | $0.11 | -$0.09 | -$0.13 | $0.13 | $0.06 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $488.54M | $460.00M | $432.97M | $432.97M | $370.98M |
| 流动资产合计 | $467.67M | $438.06M | $411.23M | $411.23M | $349.22M |
| 现金及现金等价物与短期投资 | $238.55M | $224.00M | $220.98M | $220.98M | $191.07M |
| -现金及现金等价物 | $34.12M | $34.76M | $42.91M | $42.91M | $47.12M |
| -短期投资 | $204.43M | $189.24M | $178.08M | $178.08M | $143.95M |
| 应收款 | $155.16M | $144.38M | $146.23M | $146.23M | $115.12M |
| -应收账款 | $155.16M | $144.38M | $146.23M | $146.23M | $115.12M |
| 预付资产 | $19.56M | $18.66M | $12.06M | $12.06M | $10.92M |
| 存货 | $38.88M | $37.39M | $22.63M | $22.63M | $22.42M |
| 受限现金 | $308,000.00 | $308,000.00 | $308,000.00 | $308,000.00 | $308,000.00 |
| 其他流动资产 | $15.21M | $13.32M | $9.02M | $9.02M | $9.40M |
| 非流动资产合计 | $20.87M | $21.95M | $21.74M | $21.74M | $21.75M |
| 固定资产净值 | $5.13M | $5.40M | $5.51M | $5.51M | $5.78M |
| -固定资产原值 | $5.13M | $5.40M | $8.76M | $8.76M | $5.78M |
| 商誉及其他无形资产 | $13.69M | $14.25M | $14.81M | $14.81M | $15.38M |
| 其他非流动资产 | $2.05M | $2.30M | $1.42M | $1.42M | $596,000.00 |
| 负债合计 | $267.96M | $270.36M | $243.49M | $243.49M | $212.90M |
| 流动负债合计 | $160.34M | $163.20M | $129.84M | $129.84M | $99.77M |
| 应付款 | $6.60M | $18.30M | $12.53M | $12.53M | $5.80M |
| -应付账款 | $6.60M | $18.30M | $12.53M | $12.53M | $5.80M |
| 一年内应计费用 | $131.28M | $126.63M | $95.78M | $95.78M | $74.67M |
| 短期债务及融资租赁负债 | $6.95M | $7.95M | $1.00M | $1.00M | $1.00M |
| -一年内到期债务 | $6.95M | $7.95M | $1.00M | $1.00M | $1.00M |
| 非流动负债合计 | $107.62M | $107.15M | $113.66M | $113.66M | $113.13M |
| 长期债务及融资租赁负债 | $107.19M | $106.72M | $113.23M | $113.23M | $112.77M |
| -长期债务 | $101.95M | $101.47M | $107.96M | $107.96M | $107.50M |
| -长期融资租赁负债 | $5.24M | $5.25M | $5.27M | $5.27M | $5.28M |
| 其他非流动负债 | $431,000.00 | $431,000.00 | $431,000.00 | $431,000.00 | $360,000.00 |
| 股东权益合计 | $220.58M | $189.65M | $189.48M | $189.48M | $158.07M |
| 股东权益 | $220.58M | $189.65M | $189.48M | $189.48M | $158.07M |
| 股本 | $12,000.00 | $12,000.00 | $12,000.00 | $12,000.00 | $12,000.00 |
| -普通股 | $12,000.00 | $12,000.00 | $12,000.00 | $12,000.00 | $12,000.00 |
| 资本公积 | $1.36B | $1.34B | $1.33B | $1.33B | $1.31B |
| 留存收益 | -$1.13B | -$1.15B | -$1.14B | -$1.14B | -$1.16B |
| 不影响留存收益的损益 | -$656,000.00 | -$514,000.00 | -$44,000.00 | -$44,000.00 | -$62,000.00 |
| -累计折旧 | – | – | -$3.25M | -$3.25M | – |
| -优先股 | – | – | – | – | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $12.64M | $2.24M | -$5.63M | $26.19M | -$1.75M |
| 持续经营经营活动现金流净额 | $12.64M | $2.24M | -$5.63M | $26.19M | -$1.75M |
| 持续经营净利润 | $15.01M | -$11.30M | -$16.14M | $17.40M | $7.41M |
| 折旧、折耗与摊销 | $563,000.00 | $562,000.00 | $4.67M | $563,000.00 | $562,000.00 |
| 其他非现金项目 | $757,000.00 | $675,000.00 | $2.41M | $482,000.00 | $732,000.00 |
| 营运资金变动 | -$16.23M | $1.79M | -$34.83M | -$2.33M | -$19.94M |
| -应收款变动 | -$10.79M | $1.85M | -$73.16M | -$31.11M | -$8.43M |
| -存货变动 | -$1.18M | -$14.58M | -$7.33M | -$5,000.00 | -$5.89M |
| -预付资产变动 | -$2.55M | -$11.73M | -$2.01M | -$1.27M | -$1.76M |
| -应付账款及应计费用变动 | -$1.58M | $26.38M | $48.35M | $30.18M | -$3.71M |
| -其他流动负债变动 | -$139,000.00 | -$137,000.00 | -$680,000.00 | -$126,000.00 | -$150,000.00 |
| 投资活动现金流净额 | -$15.22M | -$11.33M | -$30.25M | -$34.18M | -$25.25M |
| 持续经营投资活动现金流净额 | -$15.22M | -$11.33M | -$30.25M | -$34.18M | -$25.25M |
| 固定资产购置及出售净额 | -$158,000.00 | $0.00 | -$686,000.00 | $0.00 | $0.00 |
| 投资购置及出售净额 | -$15.07M | -$11.33M | -$19.57M | -$34.18M | -$25.25M |
| 筹资活动现金流 | $1.99M | $1.07M | $6.97M | $3.72M | $1.48M |
| 持续经营筹资活动现金流净额 | $1.99M | $1.07M | $6.97M | $3.72M | $1.48M |
| 股票期权行使所得 | $2.99M | $1.07M | $6.97M | $3.72M | $1.48M |
| 期末现金余额 | $34.43M | $35.07M | $43.22M | $43.22M | $47.43M |
| 现金净变动 | -$595,000.00 | -$8.03M | -$28.91M | -$4.27M | -$25.53M |
| 期初现金余额 | $35.07M | $43.22M | $71.95M | $47.43M | $73.05M |
| 汇率变动影响 | -$46,000.00 | -$119,000.00 | $168,000.00 | $59,000.00 | -$95,000.00 |
| 自由现金流 | $12.48M | $2.24M | -$16.31M | $26.19M | -$1.75M |
| 无形资产购置及出售净额 | – | – | -$10.00M | $0.00 | $0.00 |
| 债务发行及偿还净额 | – | – | $0.00 | – | – |
| 普通股发行净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 ARQT。
登录后参与讨论。